SCHEMBL16795682

SCHEMBL16795682

C=C(CO)c1ccc(F)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.50
CES1 P23141 2/20 0.50
MAOA P21397 6/20 0.44
MAOB P27338 6/20 0.44
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CHRNA1 P02708 1/20 0.35
CHRNG P07510 1/20 0.35
CHRNB1 P11230 1/20 0.35
CHRNB2 P17787 1/20 0.35
SLC6A2 P23975 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CHRND Q07001 1/20 0.35
PLA2G7 Q13093 1/20 0.34
KCNQ3 O43525 2/20 0.33
KCNQ2 O43526 2/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16795519 0.82 KCNQ3 (0.40) CES2CES1MAOAMAOBSLC6A3
SCHEMBL16795842 0.82 MAOA (0.48) MAOAMAOBMEN1KMT2AKCNQ3
SCHEMBL989952 0.81 CES2 (0.48) CES2CES1MAOAMAOBMEN1
SCHEMBL16795854 0.77 LMNA (0.41) MAOBRAB9A
SCHEMBL16795557 0.77 HTT (0.57) MEN1KMT2AKCNQ3KCNQ2RAB9A
SCHEMBL16795893 0.77 CES2 (0.46) CES2CES1
SCHEMBL16795520 0.75 PDE4A (0.37)
SCHEMBL16795738 0.75 PDE4A (0.37) MEN1KMT2AKCNQ3KCNQ2RAB9A
SCHEMBL26121122 0.75 MAOA (0.57) CES2CES1MAOAMAOBRAB9A
SCHEMBL16952102 0.74 CES2 (0.50) CES2CES1MAOAMAOBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO disclosed
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO disclosed